Efficient hepatic delivery of drugs: Novel strategies and their significance

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Mishra, Nidhi ^a   Yadav, Narayan Prasad ^a   Rai, Vineet Kumar ^a   Sinha, Priyam ^a   Yadav, Kuldeep Singh ^a   Jain, Sanyog ^b   Arora, Sumit ^b  

^a CSIR CENTRAL INSTITUTE OF MEDICINAL AND AROMATIC PLANTS   (India)

^b NATIONAL INSTITUTE OF PHARMACEUTICAL EDUCATION AND RESEARCH NIPER   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ASIALOFETUIN; ASIALOGLYCOPROTEIN RECEPTOR; AVIDIN; BILE ACID; DEXTRAN; DOXORUBICIN; GALACTOSAMINE; GLYCYRRHETINIC ACID; HYPERICIN; IMMUNOLIPOSOME; INSULIN DERIVATIVE; LACTOBIONIC ACID; LACTOFERRIN; LIPOSOME; MACROGOL 400; MANNOSE RECEPTOR; METHOTREXATE; MURAMYL DIPEPTIDE; NANOCARRIER; NICOTINIC ACID; PACLITAXEL; PHYXOL; PREDNISONE ACETATE; PRIMAQUINE; RHEIN; STREPTAVIDIN; UNCLASSIFIED DRUG;

BODY DISTRIBUTION; CARCINOMA CELL; CELL INTERACTION; CELL PHAGOCYTOSIS; CELL SHAPE; CELL SIZE; CELL SPECIFICITY; CHRONIC LIVER DISEASE; DRUG BINDING SITE; DRUG CONJUGATION; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG UPTAKE; HUMAN; HYDROPHILICITY; KUPFFER CELL; LIVER; LIVER CELL CARCINOMA; LIVER PARENCHYMA; MACROPHAGE; MORPHOLOGY; NONHUMAN; REVIEW; STELLATE CELL; SURFACE PROPERTY; TARGET CELL; TARGET ORGAN; CYTOLOGY; DRUG EFFECT; LIVER CELL; METABOLISM; PHAGOCYTOSIS; PHARMACOKINETICS;

DRUG DELIVERY SYSTEMS; HEPATOCYTES; HUMANS; KUPFFER CELLS; LIVER; MACROPHAGES; PHAGOCYTOSIS; PHARMACOKINETICS;

EID: 84889059244     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/382184     Document Type: Review

References (165)

1. Abe T., Masuda T., Satodate R., Phagocytic activity of Kupffer cells in splenectomized rats. Virchows Archiv A 1988 413 5 457 462 2-s2.0-0023713242
2. Wisse E., Jacobs F., Topal B., Frederik P., De Geest B., The size of endothelial fenestrae in human liver sinusoids: implications for hepatocyte-directed gene transfer. Gene Therapy 2008 15 17 1193 1199 2-s2.0-50049136079 10.1038/gt.2008.60
3. Champion J. A., Walker A., Mitragotri S., Role of particle size in phagocytosis of polymeric microspheres. Pharmaceutical Research 2008 25 8 1815 1821 2-s2.0-46749119051 10.1007/s11095-008-9562-y
4. Jiang W., Kim B. Y. S., Rutka J. T., Chan W. C. W., Nanoparticle-mediated cellular response is size-dependent. Nature Nanotechnology 2008 3 3 145 150 10.1038/nnano.2008.30 (Pubitemid 351355131)
5. Banquy X., Suarez F., Argaw A., Rabanel J.-M., Grutter P., Bouchard J.-F., Hildgen P., Giasson S., Effect of mechanical properties of hydrogel nanoparticles on macrophage cell uptake. Soft Matter 2009 5 20 3984 3991 2-s2.0-77949352944 10.1039/b821583a
6. You J.-O., Auguste D. T., Nanocarrier cross-linking density and pH sensitivity regulate intracellular gene transfer. Nano Letters 2009 9 12 4467 4473 2-s2.0-71949126830 10.1021/nl902789s
7. He C., Hu Y., Yin L., Tang C., Yin C., Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles. Biomaterials 2010 31 13 3657 3666 2-s2.0-77249104877 10.1016/j.biomaterials.2010.01.065
8. Funato K., Yoda R., Kiwada H., Contribution of complement system on destabilization of liposomes composed of hydrogenated egg phosphatidylcholine in rat fresh plasma. Biochimica et Biophysica Acta 1992 1103 2 198 204 2-s2.0-0026575128 10.1016/0005-2736(92)90087-3
9. Nishikawa K., Arai H., Inoue K., Scavenger receptor-mediated uptake and metabolism of lipid vesicles containing acidic phospholipids by mouse peritoneal macrophages. Journal of Biological Chemistry 1990 265 9 5226 5231 2-s2.0-0025219143
10. Morgan P. J., Harding S. E., Petrak K., Interactions of a model block copolymer drug delivery system with two serum proteins and myoglobin. Biochemical Society Transactions 1990 18 5 1021 1022 2-s2.0-0025053587 (Pubitemid 20359470)
11. Opanasopit P., Nishikawa M., Hashida M., Factors affecting drug and gene delivery: effects of interaction with blood components. Critical Reviews in Therapeutic Drug Carrier Systems 2002 19 3 191 233 2-s2.0-0036998323 10.1615/CritRevTherDrugCarrierSyst.v19.i3.10 (Pubitemid 36231520)
12. Boddy A., Aarons L., Petrak K., Efficiency of drug targeting: steady-state considerations using a three-compartment model. Pharmaceutical research 1989 6 5 367 372 2-s2.0-0024673329
13. Petrak K., Goddard P., Transport of macromolecules across the capillary walls. Advanced Drug Delivery Reviews 1989 3 2 191 214 2-s2.0-0024333575 (Pubitemid 19146030)
14. Ogawara K.-I., Yoshida M., Higaki K., Toshikiro Kimura T. K., Shiraishi K., Nishikawa M., Takakura Y., Hashida M., Hepatic uptake of polystyrene microspheres in rats: effect of particle size on intrahepatic distribution. Journal of Controlled Release 1999 59 1 15 22 2-s2.0-0032919807 10.1016/S0168-3659(99)00015-2 (Pubitemid 29187189)
15. Allen T. M., Hansen C., Martin F., Redemann C., Yau-Young A. F., Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochimica et Biophysica Acta 1991 1066 1 29 36 2-s2.0-0025731906 10.1016/0005-2736(91)90246-5
16. Wu J., Nantz M. H., Zern M. A., Targeting hepatocytes for drug and gene delivery: emerging novel approaches and applications. Front Biosci 2002 7 d717 d725 2-s2.0-0036518616
17. Rensen P. C. N., Sliedregt L. A. J. M., Ferns M., Kieviet E., Van Rossenberg S. M. W., Van Leeuwen S. H., Van Berkel T. J. C., Biessen E. A. L., Determination of the upper size limit for uptake and processing of ligands by the asialoglycoprotein receptor on hepatocytes in vitro and in vivo. Journal of Biological Chemistry 2001 276 40 37577 37584 2-s2.0-0035813160 10.1074/jbc.M101786200
18. Rensen P. C. N., Van Dijk M. C. M., Havenaar E. C., Bijsterbosch M. K., Kruijt J. K., Van Berkel T. J. C., Selective liver targeting of antivirals by recombinant chylomicrons - A new therapeutic approach to hepatitis B. Nature Medicine 1995 1 3 221 225 2-s2.0-0028937236
19. Wolfrum C., Shi S., Jayaprakash K. N., Jayaraman M., Wang G., Pandey R. K., Rajeev K. G., Nakayama T., Charrise K., Ndungo E. M., Zimmermann T., Koteliansky V., Manoharan M., Stoffel M., Mechanisms and optimization of in vivo delivery of lipophilic siRNAs. Nature Biotechnology 2007 25 10 1149 1157 2-s2.0-35148815670 10.1038/nbt1339 (Pubitemid 47538115)
20. Akinc A., Querbes W., De S., Qin J., Frank-Kamenetsky M., Jayaprakash K. N., Jayaraman M., Rajeev K. G., Cantley W. L., Dorkin J. R., Butler J. S., Qin L., Racie T., Sprague A., Fava E., Zeigerer A., Hope M. J., Zerial M., Sah D. W., Fitzgerald K., Tracy M. A., Manoharan M., Koteliansky V., Fougerolles A. D., Maier M. A., Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms. Molecular Therapy 2010 18 7 1357 1364 2-s2.0-77954243341 10.1038/mt.2010.85
21. Bijsterbosch M. K., Rump E. T., De Vrueh R. L. A., Dorland R., Van Veghel R., Tivel K. L., Biessen E. A. L., Van Berkel T. J. C., Manoharan M., Modulation of plasma protein binding and in vivo liver cell uptake of phosphorothioate oligodeoxynucleotides by cholesterol conjugation. Nucleic Acids Research 2000 28 14 2717 2725 2-s2.0-0034661474 (Pubitemid 30598756)
22. Wasan K. M., Brocks D. R., Lee S. D., Sachs-Barrable K., Thornton S. J., Impact of lipoproteins on the biological activity and disposition of hydrophobic drugs: implications for drug discovery. Nature Reviews Drug Discovery 2008 7 1 84 99 2-s2.0-37749000841 10.1038/nrd2353
23. Kunjachan S., Jose S., Thomas C. A., Joseph E., Kiessling F., Lammers T., Physicochemical and biological aspects of macrophage-mediated drug targeting in anti-microbial therapy. Fundamental and Clinical Pharmacology 2012 26 1 63 71 2-s2.0-84855685585 10.1111/j.1472-8206.2011.00955.x
24. Sato Y., Murase K., Kato J., Kobune M., Sato T., Kawano Y., Takimoto R., Takada K., Miyanishi K., Matsunaga T., Takayama T., Niitsu Y., Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nature Biotechnology 2008 26 4 431 442 2-s2.0-41849117310 10.1038/nbt1396 (Pubitemid 351501817)
25. Harashima H., Sakata K., Funato K., Kiwada H., Enhanced hepatic uptake of liposomes through complement activation depending on the size of liposomes. Pharmaceutical Research 1994 11 3 402 406 2-s2.0-0028224099 10.1023/A: 1018965121222 (Pubitemid 24117360)
26. Liang H.-F., Chen C.-T., Chen S.-C., Kulkarni A. R., Chiu Y.-L., Chen M.-C., Sung H.-W., Paclitaxel-loaded poly(γ -glutamic acid)-poly(lactide) nanoparticles as a targeted drug delivery system for the treatment of liver cancer. Biomaterials 2006 27 9 2051 2059 2-s2.0-28744444691 10.1016/j. biomaterials.2005.10.027 (Pubitemid 41759499)
27. Gupta P. N., Mahor S., Rawat A., Khatri K., Goyal A., Vyas S. P., Lectin anchored stabilized biodegradable nanoparticles for oral immunization. 1. Development and in vitro evaluation. International Journal of Pharmaceutics 2006 318 1-2 163 173 2-s2.0-33745500127 10.1016/j.ijpharm.2006.03.017 (Pubitemid 43963301)
28. Bibby D. C., Talmadge J. E., Dalal M. K., Kurz S. G., Chytil K. M., Barry S. E., Shand D. G., Steiert M., Pharmacokinetics and biodistribution of RGD-targeted doxorubicin-loaded nanoparticles in tumor-bearing mice. International Journal of Pharmaceutics 2005 293 1-2 281 290 2-s2.0-15044353995 10.1016/j.ijpharm.2004.12.021 (Pubitemid 40381100)
29. Stella B., Arpicco S., Peracchia M. T., Design of folic acid-conjugated nanoparticles for drug targeting. Journal of Pharmaceutical Sciences 2000 89 11 1452 1464
30. Iden D. L., Allen T. M., In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochimica et Biophysica Acta 2001 1513 2 207 216 2-s2.0-0035817346 10.1016/S0005-2736(01)00357-1 (Pubitemid 32706418)
31. Iden D. L., Allen T. M., In vitro and in vivo comparison of immunoliposomes made by conventional coupling techniques with those made by a new post-insertion approach. Biochimica et Biophysica Acta 2001 1513 2 207 216 2-s2.0-0035817346 10.1016/S0005-2736(01)00357-1 (Pubitemid 32706418)
32. Schechter B., Arnon R., Freedman Y. E., Chen L., Wilchek M., Liver accumulation of TNP-modified streptavidin and avidin: potential use for targeted radio- and chemotherapy. Journal of Drug Targeting 1996 4 3 171 179 2-s2.0-0029838251 (Pubitemid 26390299)
33. Ouchi T., Yamabe E., Hara K., Hirai M., Ohya Y., Design of attachment type of drug delivery system by complex formation of avidin with biotinyl drug model and biotinyl saccharide. Journal of Controlled Release 2004 94 2-3 281 291 2-s2.0-1642523611 10.1016/j.jconrel.2003.09.020 (Pubitemid 38117140)
34. Mamede M., Saga T., Ishimori T., Higashi T., Sato N., Kobayashi H., Brechbiel M. W., Konishi J., Hepatocyte targeting of 111In-labeled oligo-DNA with avidin or avidin-dendrimer complex. Journal of Controlled Release 2004 95 1 133 141 2-s2.0-0842330733 10.1016/j.jconrel.2003.11.015 (Pubitemid 38167687)
35. Zeng X., Sun Y.-X., Zhang X.-Z., Zhuo R.-X., Biotinylated disulfide containing PEI/avidin bioconjugate shows specific enhanced transfection efficiency in HepG2 cells. Organic and Biomolecular Chemistry 2009 7 20 4201 4210 2-s2.0-70349816972 10.1039/b910831a
36. 123I-labeled avidin: evaluation of a two-step strategy. Investigational New Drugs 2012 30 6 2132 2140 2-s2.0-83655163996 10.1007/s10637-011-9778-2
37. Wang S.-N., Deng Y.-H., Xu H., Wu H.-B., Qiu Y.-K., Chen D.-W., Synthesis of a novel galactosylated lipid and its application to the hepatocyte-selective targeting of liposomal doxorubicin. European Journal of Pharmaceutics and Biopharmaceutics 2006 62 1 32 38 2-s2.0-28444449497 10.1016/j.ejpb.2005.07.004 (Pubitemid 41736022)
38. Jeong Y.-I., Seo S.-J., Park I.-K., Lee H.-C., Kang I.-C., Akaike T., Cho C.-S., Cellular recognition of paclitaxel-loaded polymeric nanoparticles composed of poly(γ -benzyl L-glutamate) and poly(ethylene glycol) diblock copolymer endcapped with galactose moiety. International Journal of Pharmaceutics 2005 296 1-2 151 161 2-s2.0-18844389468 10.1016/j.ijpharm.2005.02. 027 (Pubitemid 40693384)
39. Hattori Y., Kawakami S., Suzuki S., Yamashita F., Hashida M., Enhancement of immune responses by DNA vaccination through targeted gene delivery using mannosylated cationic liposome formulations following intravenous administration in mice. Biochemical and Biophysical Research Communications 2004 317 4 992 999 2-s2.0-1942451887 10.1016/j.bbrc.2004.03.141 (Pubitemid 38496408)
40. Opanasopit P., Sakai M., Nishikawa M., Kawakami S., Yamashita F., Hashida M., Inhibition of liver metastasis by targeting of immunomodulators using mannosylated liposome carriers. Journal of Controlled Release 2002 80 1-3 283 294 2-s2.0-0037161342 10.1016/S0168-3659(02)00006-8 (Pubitemid 34273766)
41. Tian Q., Wang W., He X., Glycyrrhetinic acid-modified nanoparticles for drug delivery: preparation and characterization. Chinese Science Bulletin 2009 54 18 3121 3126 10.1007/s11434-009-0249-5
42. Tian Q., Zhang C.-N., Wang X.-H., Wang W., Huang W., Cha R.-T., Wang C.-H., Yuan Z., Liu M., Wan H.-Y., Tang H., Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials 2010 31 17 4748 4756 2-s2.0-77951057911 10.1016/j.biomaterials. 2010.02.042
43. Ashwell G., Harford J., Carbohydrate-specific receptors of the liver. Annual Review of Biochemistry 1982 51 531 554 2-s2.0-0020021127
44. Baenziges J. U., Fiete D., Galactose and N-acetylgalactosamine-specific endocytosis of glycopeptides by isolated rat hepatocytes. Cell 1980 22 2, part 2 611 620 2-s2.0-0019159338 (Pubitemid 11199918)
45. Kobayashi A., Goto M., Kobayashi K., Akaike T., Receptor-mediated regulation of differentiation and proliferation of hepatocytes by synthetic polymer model of asialoglycoprotein. Journal of Biomaterials Science. Polymer Edition 1994 6 4 325 342 2-s2.0-0028694644
46. Ise H., Sugihara N., Negishi N., Nikaido T., Akaike T., Low asialoglycoprotein receptor expression as markers for highly proliferative potential hepatocytes. Biochemical and Biophysical Research Communications 2001 285 2 172 182 2-s2.0-0034816926 10.1006/bbrc.2001.5139 (Pubitemid 32918051)
47. Cho C. S., Goto M., Kobayashi A., Kobayashi K., Akaike T., Effect of ligand orientation on hepatocyte attachment onto the poly(N-p-vinylbenzyl-o- β -D-galactopyranosyl-D-gluconamide) as a model ligand of asialoglycoprotein. Journal of Biomaterials Science, Polymer Edition 1996 7 12 1097 1104 2-s2.0-0029757759 (Pubitemid 26300591)
48. Iwamaru Y., Shimizu Y., Imamura M., Murayama Y., Endo R., Tagawa Y., Ushiki-Kaku Y., Takenouchi T., Kitani H., Mohri S., Yokoyama T., Okada H., Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation. Journal of Neurochemistry 2008 107 3 636 646 2-s2.0-53749089729 10.1111/j.1471-4159.2008.05628.x
49. Suzuki Y. A., Lopez V., Lönnerdal B., Mammalian lactoferrin receptors: structure and function. Cellular and Molecular Life Sciences 2005 62 22 2560 2575 2-s2.0-28344453346 10.1007/s00018-005-5371-1 (Pubitemid 41721230)
50. Ward P. P., Uribe-Luna S., Conneely O. M., Lactoferrin and host defense. Biochemistry and Cell Biology 2002 80 1 95 102 2-s2.0-0036190858 10.1139/o01-214 (Pubitemid 34194233)
51. Huang R., Ke W., Liu Y., Jiang C., Pei Y., The use of lactoferrin as a ligand for targeting the polyamidoamine-based gene delivery system to the brain. Biomaterials 2008 29 2 238 246 2-s2.0-35548959221 10.1016/j.biomaterials.2007. 09.024 (Pubitemid 350016299)
52. Chen H., Tang L., Qin Y., Yin Y., Tang J., Tang W., Sun X., Zhang Z., Liu J., He Q., Lactoferrin-modified procationic liposomes as a novel drug carrier for brain delivery. European Journal of Pharmaceutical Sciences 2010 40 2 94 102 2-s2.0-77952239864 10.1016/j.ejps.2010.03.007
53. Wei M., Xu Y., Zou Q., Tu L., Tang C., Xu T., Deng L., Wu C., Hepatocellular carcinoma targeting effect of PEGylated liposomes modified with lactoferrin. European Journal of Pharmaceutical Sciences 2012 46 3 131 141 2-s2.0-84859430213 10.1016/j.ejps.2012.02.007
54. Gorria M., Tekpli X., Rissel M., Sergent O., Huc L., Landvik N., Fardel O., Dimanche-Boitrel M.-T., Holme J. A., Lagadic-Gossmann D., A new lactoferrin- and iron-dependent lysosomal death pathway is induced by benzo[a]pyrene in hepatic epithelial cells. Toxicology and Applied Pharmacology 2008 228 2 212 224 2-s2.0-41549141262 10.1016/j.taap.2007.12.021
55. Bennatt D. J., McAbee D. D., Identification and isolation of a 45-kKa calcium-dependent lactoferrin receptor from rat hepatocytes. Biochemistry 1997 36 27 8359 8366 2-s2.0-0030807614 10.1021/bi963078u (Pubitemid 27297547)
56. Bennatt D. J., Ling Y. Y., McAbee D. D., Isolated rat hepatocytes bind lactoferrins by the RHL-1 subunit of the asialoglycoprotein receptor in a galactose-independent manner. Biochemistry 1997 36 27 8367 8376 2-s2.0-0342981704 10.1021/bi963079m (Pubitemid 27297548)
57. McAbee D. D., Jiang X., Walsh K. B., Lactoferrin binding to the rat asialoglycoprotein receptor requires the receptor's lectin properties. Biochemical Journal 2000 348 1 113 117 2-s2.0-0034657165 10.1042/0264-6021: 3480113 (Pubitemid 30312138)
58. McAbee D. D., Bennatt D. J., Yuan Yuan Ling Y. Y. L., Identification and analysis of a CA2+-dependent lactoferrin receptor in rat liver: lactoferrin binds to the asialoglycoprotein receptor in a galactose-independent manner. Advances in Experimental Medicine and Biology 1998 443 113 121 2-s2.0-0031693811 (Pubitemid 28432177)
59. Pathak A., Vyas S. P., Gupta K. C., Nano-vectors for efficient liver specific gene transfer. International Journal of Nanomedicine 2008 3 1 31 49 2-s2.0-66449094611 (Pubitemid 351517074)
60. Kamruzzaman Selim K. M., Ha Y.-S., Kim S.-J., Chang Y., Kim T.-J., Ho Lee G., Kang I.-K., Surface modification of magnetite nanoparticles using lactobionic acid and their interaction with hepatocytes. Biomaterials 2007 28 4 710 716 2-s2.0-33751064108 10.1016/j.biomaterials.2006.09.014 (Pubitemid 44754877)
61. Kamruzzaman Selim K. M., Xing Z.-C., Guo H., Kang I.-K., Immobilization of lactobionic acid on the surface of cadmium sulfide nanoparticles and their interaction with hepatocytes. Journal of Materials Science 2009 20 9 1945 1953 2-s2.0-68849083964 10.1007/s10856-009-3741-1
62. Díez S., Navarro G., de ILarduya C. T., In vivo targeted gene delivery by cationic nanoparticles for treatment of hepatocellular carcinoma. Journal of Gene Medicine 2009 11 1 38 45 2-s2.0-59449091692 10.1002/jgm.1273
63. Maitani Y., Kawano K., Yamada K., Nagai T., Takayama K., Efficiency of liposomes surface-modified with soybean-derived sterylglucoside as a liver targeting carrier in HepG2 cells. Journal of Controlled Release 2001 75 3 381 389 2-s2.0-0035839216 10.1016/S0168-3659(01)00411-4 (Pubitemid 32727267)
64. Qi X.-R., Yan W.-W., Shi J., Hepatocytes targeting of cationic liposomes modified with soybean sterylglucoside and polyethylene glycol. World Journal of Gastroenterology 2005 11 32 4947 4952 2-s2.0-24144461164 (Pubitemid 41227190)
65. Shi J., Qi X.-R., Yang L., Fei R., Wei L., Liver targeting of cationic liposomes modified with soybean-derived sterylglucoside in vitro. Yaoxue Xuebao 2006 41 1 19 23 2-s2.0-33644814531 (Pubitemid 43350965)
66. Negishi M., Irie A., Nagata N., Ichikawa A., Specific binding of glycyrrhetinic acid to the rat liver membrane. Biochimica et Biophysica Acta 1991 1066 1 77 82 2-s2.0-0025805614 10.1016/0005-2736(91)90253-5
67. Clerc T., Sbarra V., Botta-Fridlund D., Lafont H., Pak-Leung P., Gauthier A., Chanussot F., Bile salt secretion by hepatocytes incubated with bile salts and liposomes or low density lipoproteins. Life Sciences 1995 56 4 277 286 2-s2.0-0028872242 10.1016/0024-3205(94)00922-8 (Pubitemid 124015451)
68. Pütz G., Schmider W., Nitschke R., Kurz G., Blum H. E., Synthesis of phospholipid-conjugated bile salts and interaction of bile salt-coated liposomes with cultured hepatocytes. Journal of Lipid Research 2005 46 11 2325 2338 2-s2.0-27444444137 10.1194/jlr.M500144-JLR200 (Pubitemid 41532521)
69. Sahagian G. G., Distler J., Jourdian G. W., Characterization of a membrane-associated receptor from bovine liver that binds phosphomannosyl residues of bovine testicular beta-galactosidase. Proceedings of the National Academy of Sciences of the United States of America 1981 78 7 4289 4293 2-s2.0-0019590652
70. Jayasree A., Sasidharan S., Koyakutty M., Nair S., Menon D., Mannosylated chitosan-zinc sulphide nanocrystals as fluorescent bioprobes for targeted cancer imaging. Carbohydrate Polymers 2011 85 1 37 43 2-s2.0-79953653213 10.1016/j.carbpol.2011.01.034
71. Rieger J., Freichels H., Imberty A., Putaux J.-L., Delair T., Jérôme C., Auzély-Velty R., Polyester nanoparticles presenting mannose residues: toward the development of new vaccine delivery systems combining biodegradability and targeting properties. Biomacromolecules 2009 10 3 651 657 2-s2.0-65249103898 10.1021/bm801492c
72. Kawakami S., Sato A., Nishikawa M., Yamashita F., Hashida M., Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Therapy 2000 7 4 292 299 2-s2.0-0033995526 (Pubitemid 30119732)
73. Muriel P., Moreno M. G., Hernández M. D. C., Chávez E., Alcantar L. K., Resolution of liver fibrosis in chronic CCl4 administration in the rat after discontinuation of treatment: effect of silymarin, silibinin, colchicine and trimethylcolchicinic acid. Basic and Clinical Pharmacology and Toxicology 2005 96 5 375 380 2-s2.0-18744393745 10.1111/j.1742-7843.2005.pto-06. x (Pubitemid 40676591)
74. Suojanen J., Vilen S.-T., Nyberg P., Heikkilä P., Penate-Medina O., Saris P. E. J., Hagström J., Ranta T.-M., Salo T., Sorsa T., Reunanen J., Selective gelatinase inhibitor peptide is effective in targeting tongue carcinoma cell tumors in vivo. Anticancer Research 2011 31 11 3659 3664 2-s2.0-83055187109
75. Shen Z., Wei W., Tanaka H., Kohama K., Ma G., Dobashi T., Maki Y., Wang H., Bi J., Dai S., A galactosamine-mediated drug delivery carrier for targeted liver cancer therapy. Pharmacological Research 2011 64 4 410 419 2-s2.0-80052969743 10.1016/j.phrs.2011.06.015
76. Beljaars L., Poelstra K., Molema G., Meijer D. K. F., Targeting of sugar- and charge-modified albumins to fibrotic rat livers: the accessibility of hepatic cells after chronic bile duct ligation. Journal of Hepatology 1998 29 4 579 588 2-s2.0-0032191706 10.1016/S0168-8278(98)80153-0 (Pubitemid 28484947)
77. Biessen E. A. L., Beuting D. M., Vietsch H., Bijsterbosch M. K., Van Berkel T. J. C., Specific targeting of the antiviral drug 5-Iodo 2'-deoxyuridine to the parenchymal liver cell using lactosylated poly-L-lysine. Journal of Hepatology 1994 21 5 806 815 2-s2.0-0028029889 10.1016/S0168-8278(94)80243-2 (Pubitemid 24374148)
78. Schechter B., Chen L., Arnon R., Wilchek M., Organ selective delivery using a tissue-directed sreptavidin-biotin system: targeting 5-fluorouridine via TNP-streptavidin. Journal of Drug Targeting 1999 6 5 337 348 2-s2.0-0032957192 (Pubitemid 29237590)
79. Yuan L., Wang J., Shen W.-C., Reversible lipidization of somatostatin analogues for the liver targeting. European Journal of Pharmaceutics and Biopharmaceutics 2008 70 2 615 620 2-s2.0-52949146348 10.1016/j.ejpb.2008.05.004
80. Han J.-H., Oh Y.-K., Kim D.-S., Kim C.-K., Enhanced hepatocyte uptake and liver targeting of methotrexate using galactosylated albumin as a carrier. International Journal of Pharmaceutics 1999 188 1 39 47 2-s2.0-0032822827 10.1016/S0378-5173(99)00206-9 (Pubitemid 29472458)
81. Wu D.-Q., Lu B., Chang C., Chen C.-S., Wang T., Zhang Y.-Y., Cheng S.-X., Jiang X.-J., Zhang X.-Z., Zhuo R.-X., Galactosylated fluorescent labeled micelles as a liver targeting drug carrier. Biomaterials 2009 30 7 1363 1371 2-s2.0-58149191211 10.1016/j.biomaterials.2008.11.027
82. Zhang J., Li C., Xue Z.-Y., Cheng H.-W., Huang F.-W., Zhuo R.-X., Zhang X.-Z., Fabrication of lactobionic-loaded chitosan microcapsules as potential drug carriers targeting the liver. Acta Biomaterialia 2011 7 4 1665 1673 2-s2.0-79952184157 10.1016/j.actbio.2010.11.042
83. Bhadra D., Yadav A. K., Bhadra S., Jain N. K., Glycodendrimeric nanoparticulate carriers of primaquine phosphate for liver targeting. International Journal of Pharmaceutics 2005 295 1-2 221 233 2-s2.0-17644395605 10.1016/j.ijpharm.2005.01.026 (Pubitemid 40558805)
84. Sandrine C. M., Targeting approaches. Nanotherapeutics 2008 Pan Stanford Publishing 67 89
85. Zhao R., Liu S., Mao S., Wang Y., Study on liver targeting effect of vinegar-baked Radix Bupleuri on resveratrol in mice. Journal of Ethnopharmacology 2009 126 3 415 420 2-s2.0-70449646164 10.1016/j.jep.2009.09. 023
86. Chen L., Schechter B., Arnon R., Wilchek M., Tissue selective affinity targeting using the avidin-biotin system. Drug Development Research 2000 50 3-4 258 271 2-s2.0-0033809518
87. Di Stefano G., Busi C., Derenzini M., Trerè D., Fiume L., Conjugation of 5-fluoro-2′-deoxyuridine with lactosaminated poly-1-lysine to reduce extrahepatic toxicity in the treatment of hepatocarcinomas. Italian Journal of Gastroenterology and Hepatology 1998 30 2 173 177 2-s2.0-0031851898
88. Torchilin V. P., Drug targeting. European Journal of Pharmaceutical Sciences 2000 11 2 S81 S91 2-s2.0-0033800221 10.1016/S0928-0987(00)00166-4
89. Bijsterbosch M. K., Van De Bilt H., Van Berkel T. J. C., Specific targeting of a lipophilic prodrug of iododeoxyuridine to parenchymal liver cells using lactosylated reconstituted high density lipoprotein particles. Biochemical Pharmacology 1996 52 1 113 121 2-s2.0-0029952026 10.1016/0006-2952(96)00170-0 (Pubitemid 26199113)
90. Dierling A. M., Cui Z., Targeting primaquine into liver using chylomicron emulsions for potential vivax malaria therapy. International Journal of Pharmaceutics 2005 303 1-2 143 152 2-s2.0-24944506410 10.1016/j.ijpharm.2005.07. 015 (Pubitemid 41318031)
91. Lai L. F., Guo H. X., Preparation of new 5-fluorouracil-loaded zein nanoparticles for liver targeting. International Journal of Pharmaceutics 2011 404 1-2 317 323 2-s2.0-78650679616 10.1016/j.ijpharm.2010.11.025
92. Beljaars L., Albumin modified with mannose 6-phosphate: a potential carrier for selective delivery of antifibrotic drugs to rat and human hepatic stellate cells. Hepatology 1999 29 5 1486 1493 2-s2.0-0032899156 10.1002/hep.510290526 (Pubitemid 29211051)
93. Wang B., Li W., Guo K., Xiao Y., Wang Y., Fan J., MiR-181b Promotes hepatic stellate cells proliferation by targeting p27 and is elevated in the serum of cirrhosis patients. Biochemical and Biophysical Research Communications 2012 421 1 4 8 2-s2.0-84860329438 10.1016/j.bbrc.2012.03.025
94. Elrick L. J., Leel V., Blaylock M. G., Duncan L., Drever M. R., Strachan G., Charlton K. A., Koruth M., Porter A. J., Wright M. C., Generation of a monoclonal human single chain antibody fragment to hepatic stellate cells-a potential mechanism for targeting liver anti-fibrotic therapeutics. Journal of Hepatology 2005 42 6 888 896 2-s2.0-21044445446 10.1016/j.jhep.2005.01.028 (Pubitemid 40693206)
95. Huang W., Wang W., Wang P., Tian Q., Zhang C., Wang C., Yuan Z., Liu M., Wan H., Tang H., Glycyrrhetinic acid-modified poly(ethylene glycol)-b- poly(γ -benzyl l-glutamate) micelles for liver targeting therapy. Acta Biomaterialia 2010 6 10 3927 3935 2-s2.0-77956189395 10.1016/j.actbio.2010.04. 021
96. Li X., Wu Q., Chen Z., Gong X., Lin X., Preparation, characterization and controlled release of liver-targeting nanoparticles from the amphiphilic random copolymer. Polymer 2008 49 22 4769 4775 2-s2.0-53249107455 10.1016/j.polymer. 2008.09.006
97. Ma P., Liu S., Huang Y., Chen X., Zhang L., Jing X., Lactose mediated liver-targeting effect observed by ex vivo imaging technology. Biomaterials 2010 31 9 2646 2654 2-s2.0-74449088540 10.1016/j.biomaterials.2009.12.019
98. Gonzalo T., Talman E. G., Van De Ven A., Temming K., Greupink R., Beljaars L., Reker-Smit C., Meijer D. K. F., Molema G., Poelstra K., Kok R. J., Selective targeting of pentoxifylline to hepatic stellate cells using a novel platinum-based linker technology. Journal of Controlled Release 2006 111 1-2 193 203 2-s2.0-33344459215 10.1016/j.jconrel.2005.12.010 (Pubitemid 43290008)
99. Jiang H.-L., Kwon J.-T., Kim E.-M., Kim Y.-K., Arote R., Jere D., Jeong H.-J., Jang M.-K., Nah J.-W., Xu C.-X., Park I.-K., Cho M.-H., Cho C.-S., Galactosylated poly(ethylene glycol)-chitosan-graft-polyethylenimine as a gene carrier for hepatocyte-targeting. Journal of Controlled Release 2008 131 2 150 157 2-s2.0-53049087253 10.1016/j.jconrel.2008.07.029
100. Hashida M., Nishikawa M., Takakura Y., Hepatic targeting of drugs and proteins by chemical modification. Journal of Controlled Release 1995 36 1-2 99 107 2-s2.0-0029091626 10.1016/0168-3659(95)00050-I
101. Xu Y., Jin X., Ping Q., Cheng J., Sun M., Cao F., You W., Yuan D., A novel lipoprotein-mimic nanocarrier composed of the modified protein and lipid for tumor cell targeting delivery. Journal of Controlled Release 2010 146 3 299 308 2-s2.0-77956288758 10.1016/j.jconrel.2010.05.022
102. Hu Y., Shen Y., Ji B., Yin S., Ren X., Chen T., Ma Y., Zhang Z., Zhang Y., Liver-specific gene therapy of hepatocellular carcinoma by targeting human telomerase reverse transcriptase with pegylated immuno-lipopolyplexes. European Journal of Pharmaceutics and Biopharmaceutics 2011 78 3 320 325 2-s2.0-79960581539 10.1016/j.ejpb.2010.12.036
103. Swart P. J., Hirano T., Kuipers M. E., Ito Y., Smit C., Hashida M., Nishikawa M., Beljaars L., Meijer D. K. F., Poelstra K., Targeting of superoxide dismutase to the liver results in anti- inflammatory effects in rats with fibrotic livers. Journal of Hepatology 1999 31 6 1034 1043 2-s2.0-0032737432 10.1016/S0168-8278(99)80316-X
104. Hattori Y., Kawakami S., Yamashita F., Hashida M., Controlled biodistribution of galactosylated liposomes and incorporated probucol in hepatocyte-selective drug targeting. Journal of Controlled Release 2000 69 3 369 377 2-s2.0-0034602604 10.1016/S0168-3659(00)00338-2
105. Danhier F., Vroman B., Lecouturier N., Crokart N., Pourcelle V., Freichels H., Jérôme C., Marchand-Brynaert J., Feron O., Préat V., Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with Paclitaxel. Journal of Controlled Release 2009 140 2 166 173 2-s2.0-70350619897 10.1016/j.jconrel.2009.08.011
106. Li F., Sun J.-Y., Wang J.-Y., Du S.-L., Lu W.-Y., Liu M., Xie C., Shi J.-Y., Effect of hepatocyte growth factor encapsulated in targeted liposomes on liver cirrhosis. Journal of Controlled Release 2008 131 1 77 82 2-s2.0-52049106824 10.1016/j.jconrel.2008.07.021
107. Huang G., Diakur J., Xu Z., Wiebe L. I., Asialoglycoprotein receptor-targeted superparamagnetic iron oxide nanoparticles. International Journal of Pharmaceutics 2008 360 1-2 197 203 2-s2.0-47049093646 10.1016/j.ijpharm.2008.04.029
108. Maeng J. H., Lee D.-H., Jung K. H., Bae Y.-H., Park I.-S., Jeong S., Jeon Y.-S., Shim C.-K., Kim W., Kim J., Lee J., Lee Y.-M., Kim J.-H., Kim W.-H., Hong S.-S., Multifunctional doxorubicin loaded superparamagnetic iron oxide nanoparticles for chemotherapy and magnetic resonance imaging in liver cancer. Biomaterials 2010 31 18 4995 5006 2-s2.0-77951976128 10.1016/j.biomaterials. 2010.02.068
109. Becker S., Spiess M., Klenk H.-D., The asialoglycoprotein receptor is a potential liver-specific receptor for Marburg virus. Journal of General Virology 1995 76 2 393 399 2-s2.0-0028872697
110. Zhang X.-Q., Wang X.-L., Zhang P.-C., Liu Z.-L., Zhuo R.-X., Mao H.-Q., Leong K. W., Galactosylated ternary DNA/polyphosphoramidate nanoparticles mediate high gene transfection efficiency in hepatocytes. Journal of Controlled Release 2005 102 3 749 763 2-s2.0-12844281900 10.1016/j.jconrel.2004.10.024 (Pubitemid 40170216)
111. Singh M., Ariatti M., Targeted gene delivery into HepG2 cells using complexes containing DNA, cationized asialoorosomucoid and activated cationic liposomes. Journal of Controlled Release 2003 92 3 383 394 2-s2.0-1642362613 10.1016/S0168-3659(03)00360-2 (Pubitemid 38366160)
112. Shinoda T., Maeda A., Kagatani S., Konno Y., Sonobe T., Fukui M., Hashimoto H., Hara K., Fujita K., Specific interaction between galactose branched-cyclodextrins and hepatocytes in vitro. International Journal of Pharmaceutics 1998 167 1-2 147 154 2-s2.0-0032103813 10.1016/S0378-5173(98) 00058-1 (Pubitemid 28341516)
113. Harashima H., Kiwada H., Liposomal targeting and drug delivery: kinetic consideration. Advanced Drug Delivery Reviews 1996 19 3 425 444 2-s2.0-0030580954 10.1016/0169-409X(96)00012-9 (Pubitemid 26227529)
114. Lin A., Liu Y., Huang Y., Sun J., Wu Z., Zhang X., Ping Q., Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery. International Journal of Pharmaceutics 2008 359 1-2 247 253 2-s2.0-44749092859 10.1016/j.ijpharm.2008.03.039
115. Tian Q., Zhang C.-N., Wang X.-H., Wang W., Huang W., Cha R.-T., Wang C.-H., Yuan Z., Liu M., Wan H.-Y., Tang H., Glycyrrhetinic acid-modified chitosan/poly(ethylene glycol) nanoparticles for liver-targeted delivery. Biomaterials 2010 31 17 4748 4756 2-s2.0-77951057911 10.1016/j.biomaterials. 2010.02.042
116. Gratton S. E., Ropp P. A., Pohlhaus P. D., The effect of particle design on cellular internalization pathways. Proceedings of the National Academy of Sciences of USA 2008 105 33 11613 11618 10.1073/pnas.0801763105
117. Sharma G., Valenta D. T., Altman Y., Harvey S., Xie H., Mitragotri S., Smith J. W., Polymer particle shape independently influences binding and internalization by macrophages. Journal of Controlled Release 2010 147 3 408 412 2-s2.0-78049465753 10.1016/j.jconrel.2010.07.116
118. Geng Y., Dalhaimer P., Cai S., Tsai R., Tewari M., Minko T., Discher D. E., Shape effects of filaments versus spherical particles in flow and drug delivery. Nature Nanotechnology 2007 2 4 249 255 2-s2.0-34248402413 10.1038/nnano.2007.70 (Pubitemid 46739812)
119. Lin S.-Y., Hsu W.-H., Lo J.-M., Tsai H.-C., Hsiue G.-H., Novel geometry type of nanocarriers mitigated the phagocytosis for drug delivery. Journal of Controlled Release 2011 154 1 84 92 2-s2.0-79960901440 10.1016/j.jconrel.2011. 04.023
120. Arnida A., Janát-Amsbury M. M., Ray A., Peterson C. M., Ghandehari H., Geometry and surface characteristics of gold nanoparticles influence their
121. Decuzzi P., Godin B., Tanaka T., Lee S.-Y., Chiappini C., Liu X., Ferrari M., Size and shape effects in the biodistribution of intravascularly injected particles. Journal of Controlled Release 2010 141 3 320 327 2-s2.0-75549087322 10.1016/j.jconrel.2009.10.014
122. Doshi N., Prabhakarpandian B., Rea-Ramsey A., Pant K., Sundaram S., Mitragotri S., Flow and adhesion of drug carriers in blood vessels depend on their shape: a study using model synthetic microvascular networks. Journal of Controlled Release 2010 146 2 196 200 2-s2.0-77955413581 10.1016/j.jconrel.2010. 04.007
123. Liu Z., Cai W., He L., Nakayama N., Chen K., Sun X., Chen X., Dai H., In vivo biodistribution and highly efficient tumour targeting of carbon nanotubes in mice. Nature Nanotechnology 2007 2 1 47 52 2-s2.0-33846845060 10.1038/nnano.2006.170 (Pubitemid 46210038)
124. Beningo K. A., Wang Y.-L., Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. Journal of Cell Science 2002 115 4 849 856 2-s2.0-0037084460 (Pubitemid 34196344)
125. Yamashita C., Matsuo H., Akiyama K., Kiwada H., Enhancing effect of cetylmannoside on targeting of liposomes to Kupffer cells in rats. International Journal of Pharmaceutics 1991 70 3 225 233 2-s2.0-0025904202 10.1016/0378-5173(91)90286-W
126. Melgert B. N., Olinga P., Van Der Laan J. M. S., Weert B., Cho J., Schuppan D., Groothuis G. M. M., Meijer D. K. F., Poelstra K., Targeting dexamethasone to Kupffer cells: effects on liver inflammation and fibrosis in rats. Hepatology 2001 34 4 719 728 2-s2.0-0034802467 10.1053/jhep.2001.27805 (Pubitemid 32927996)
127. Merkel T. J., Jones S. W., Herlihy K. P., Kersey F. R., Shields A. R., Napier M., Luft J. C., Wu H., Zamboni W. C., Wang A. Z., Bear J. E., DeSimone J. M., Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles. Proceedings of the National Academy of Sciences of the United States of America 2011 108 2 586 591 2-s2.0-79551679772 10.1073/pnas.1010013108
128. Hillaireau H., Couvreur P., Nanocarriers' entry into the cell: relevance to drug delivery. Cellular and Molecular Life Sciences 2009 66 17 2873 2896 2-s2.0-68949208465 10.1007/s00018-009-0053-z
129. Schuppan D., Ruehl M., Somasundaram R., Hahn E. G., Matrix as a modulator of hepatic fibrogenesis. Seminars in Liver Disease 2001 21 3 351 372 2-s2.0-0034808233 10.1055/s-2001-17556 (Pubitemid 32923765)
130. Benyon R. C., Arthur M. J. P., Extracellular matrix degradation and the role of hepatic stellate cells. Seminars in Liver Disease 2001 21 3 373 384 2-s2.0-0034814405 10.1055/s-2001-17552 (Pubitemid 32923766)
131. Rockey D. C., Hepatic blood flow regulation by stellate cells in normal and injured liver. Seminars in Liver Disease 2001 21 3 337 349 2-s2.0-0034804406 10.1055/s-2001-17551 (Pubitemid 32923764)
132. Lück M., Paulke B. R., Schröder W., Blunk T., Müller R. H., Analysis of plasma protein adsorption on polymeric nanoparticles with different surface characteristics. Journal of Biomedical Materials Research 1998 39 3 478 485 (Pubitemid 28063466)
133. Greupink R., Bakker H. I., Reker-Smit C., Van Loenen-Weemaes A.-M., Kok R.-J., Meijer D. K. F., Beljaars L., Poelstra K., Studies on the targeted delivery of the antifibrogenic compound mycophenolic acid to the hepatic stellate cell. Journal of Hepatology 2005 43 5 884 892 2-s2.0-26244454363 10.1016/j.jhep.2005.04.014 (Pubitemid 41414515)
134. Adrian J. E., Kamps J. A. A. M., Scherphof G. L., Meijer D. K. F., van Loenen-Weemaes A.-M., Reker-Smit C., Terpstra P., Poelstra K., A novel lipid-based drug carrier targeted to the non-parenchymal cells, including hepatic stellate cells, in the fibrotic livers of bile duct ligated rats. Biochimica et Biophysica Acta 2007 1768 6 1430 1439 2-s2.0-34249002289 10.1016/j.bbamem.2007.03.027 (Pubitemid 46795479)
135. Raz A., Bucana C., Fogler W. E., Biochemical, morphological, and ultrastructural studies on the uptake of liposomes by murine macrophages. Cancer Research 1981 41 2 487 494 2-s2.0-0019364294 (Pubitemid 11179386)
136. Chonn A., Semple S. C., Cullis P. R., Association of blood proteins with large unilamellar liposomes in vivo. Relation to circulation lifetimes. Journal of Biological Chemistry 1992 267 26 18759 18765 2-s2.0-0026778635
137. Xiao K., Li Y., Luo J., Lee J. S., Xiao W., Gonik A. M., Agarwal R. G., Lam K. S., The effect of surface charge on in vivo biodistribution of PEG-oligocholic acid based micellar nanoparticles. Biomaterials 2011 32 13 3435 3446 2-s2.0-79952008706 10.1016/j.biomaterials.2011.01.021
138. Mori A., Klibanov A. L., Torchilin V. P., Huang L., Influence of the steric barrier activity of amphipathic poly(ethyleneglycol) and ganglioside GM1 on the circulation time of liposomes and on the target binding of immunoliposomes in vivo. FEBS Letters 1991 284 2 263 266 2-s2.0-0025854252 10.1016/0014-5793(91)80699-4
139. Gabizon A., Papahadjopoulos D., Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proceedings of the National Academy of Sciences of the United States of America 1988 85 18 6949 6953 2-s2.0-0842279809
140. Peer D., Margalit R., Tumor-targeted hyaluronan nanoliposomes increase the antitumor activity of liposomal doxorubicin in syngeneic and human xenograft mouse tumor models. Neoplasia 2004 6 4 343 353 2-s2.0-3142783426 10.1593/neo.03460 (Pubitemid 38924849)
141. Liu D., Liu F., Song Y. K., Monosialoganglioside GM1 shortens the blood circulation time of liposomes in rats. Pharmaceutical Research 1995 12 4 508 512 2-s2.0-0028986113
142. Liu D., Song Y. K., Liu F., Antibody dependent, complement mediated liver uptake of liposomes containing GM1. Pharmaceutical Research 1995 12 11 1775 1780 2-s2.0-0029587262 10.1023/A:1016286310475 (Pubitemid 26004701)
143. Liu D., Hu Q., Song Y. K., Liposome clearance from blood: different animal species have different mechanisms. Biochimica et Biophysica Acta 1995 1240 2 277 284 2-s2.0-0029557860 10.1016/0005-2736(95)00184-0 (Pubitemid 26004752)
144. Rigotti A., Acton S. L., Krieger M., The class B scavenger receptors SR-BI and CD36 are receptors for anionic phospholipids. Journal of Biological Chemistry 1995 270 27 16221 16224 2-s2.0-0028997232 10.1074/jbc.270.27.16221
145. Yu Q., Shao R., Qian H. S., George S. E., Rockey D. C., Gene transfer of the neuronal NO synthase isoform to cirrhotic rat liver ameliorates portal hypertension. Journal of Clinical Investigation 2000 105 6 741 748 2-s2.0-0034121518 (Pubitemid 30164112)
146. Qi Z., Atsuchi N., Ooshima A., Takeshita A., Ueno H., Blockade of type β transforming growth factor signaling prevents liver fibrosis and dysfunction in the rat. Proceedings of the National Academy of Sciences of the United States of America 1999 96 5 2345 2349 2-s2.0-0033515099 10.1073/pnas.96.5.2345 (Pubitemid 29117917)
147. Rudolph K. L., Chang S., Millard M., Schreiber-Agus N., DePinho R. A., Inhibition of experimental liver cirrhosis in mice by telomerase gene delivery. Science 2000 287 5456 1253 1258 2-s2.0-0034681457 10.1126/science.287.5456.1253 (Pubitemid 30112145)
148. Salgado S., Garcia J., Vera J., Siller F., Bueno M., Miranda A., Segura A., Grijalva G., Segura J., Orozco H., Hernandez-Pando R., Fafutis M., Aguilar L. K., Aguilar-Cordova E., Armendariz-Borunda J., Liver cirrhosis is reverted by urokinase-type plasminogen activator gene therapy. Molecular Therapy 2000 2 6 545 551 2-s2.0-0034567343 10.1006/mthe.2000.0210
149. Terpstra V., Van Berkel T. J. C., Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood 2000 95 6 2157 2163 2-s2.0-0034653976 (Pubitemid 30151660)
150. Oja C. D., Semple S. C., Chonn A., Cullis P. R., Influence of dose on liposome clearance: critical role of blood proteins. Biochimica et Biophysica Acta 1996 1281 1 31 37 2-s2.0-0029971068 10.1016/0005-2736(96)00003-X (Pubitemid 26178845)
151. Allen T. M., Hansen C., Pharmacokinetics of stealth versus conventional liposomes: effect of dose. Biochimica et Biophysica Acta 1991 1068 2 133 141 2-s2.0-0025789143 10.1016/0005-2736(91)90201-I
152. Panagi Z., Beletsi A., Evangelatos G., Livaniou E., Ithakissios D. S., Avgoustakis K., Effect of dose on the biodistribution and pharmacokinetics of PLGA and PLGA-mPEG nanoparticles. International Journal of Pharmaceutics 2001 221 1-2 143 152 2-s2.0-0035912958 10.1016/S0378-5173(01)00676-7 (Pubitemid 32524042)
153. Chow D. D., Essien H. E., Padki M. M., Hwang K. J., Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect. Journal of Pharmacology and Experimental Therapeutics 1989 248 2 506 513 2-s2.0-0024603656 (Pubitemid 19090216)
154. Van Etten E. W. M., Ten Kate M. T., Snijders S. V., Bakker-Woudenberg I. A. J. M., Administration of liposomal agents and blood clearance capacity of the mononuclear phagocyte system. Antimicrobial Agents and Chemotherapy 1998 42 7 1677 1681 2-s2.0-0031862258 (Pubitemid 28311561)
155. Harashima H., Sakata K., Kiwada H., Distinction between the depletion of opsonins and the saturation of uptake in the dose-dependent hepatic uptake of liposomes. Pharmaceutical Research 1993 10 4 606 610 2-s2.0-0027467823 10.1023/A:1018918623658 (Pubitemid 23113057)
156. Gabizon A., Tzemach D., Mak L., Bronstein M., Horowitz A. T., Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine models. Journal of Drug Targeting 2002 10 7 539 548 2-s2.0-0036875746 10.1080/1061186021000072447 (Pubitemid 36124352)
157. Andresen T. L., Jensen S. S., Jørgensen K., Advanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific drug release. Progress in Lipid Research 2005 44 1 68 97 2-s2.0-14644399827 10.1016/j.plipres.2004.12.001 (Pubitemid 40313220)
158. Chellat F., Merhi Y., Moreau A., Yahia L., Therapeutic potential of nanoparticulate systems for macrophage targeting. Biomaterials 2005 26 35 7260 7275 2-s2.0-23644437163 10.1016/j.biomaterials.2005.05.044 (Pubitemid 41133578)
159. Williams P. L., Gray H., Gray's Anatomy: The Anatomical Basis of Medicine and Surgery 1995 Churchill Livingstone
160. Body Atlas 2008 Octopus Books
161. Guyton A. C., Textbook of Medical Physiology 1981 Saunders
162. Cheng M., He B., Wan T., 5-Fluorouracil nanoparticles inhibit hepatocellular carcinoma via activation of the p53 pathway in the orthotopic transplant mouse model. PLoS One 2012 7 10, article e47115
163. Li X., Xu H., Dai X., Zhu Z., Liu B., Lu X., Enhanced in vitro and in vivo therapeutic efficacy of codrug-loaded nanoparticles against liver cancer. International Journal of Nanomedicine 2012 7 5183 5190
164. Zhou X., Zhang M., Yung B., Lactosylated liposomes for targeted delivery of doxorubicin to hepatocellular carcinoma. International Journal of Nanomedicine 2012 7 5465 5474
165. Zhang X., Zhang X., Yu P., Hydrotropic polymeric mixed micelles based on functional hyperbranched polyglycerol copolymers as hepatoma-targeting drug delivery system. Journal of Pharmaceutical Sciences 2013 102 1 145 1453